Document Detail


Retrospective analysis of pulsed radiofrequency energy therapy use in the treatment of chronic pressure ulcers.
MedLine Citation:
PMID:  22610109     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
OBJECTIVE: : The purpose of the study was to evaluate the benefit of using pulsed radiofrequency energy (PRFE) therapy in the treatment of chronic pressure ulcers.
DESIGN: : A retrospective analysis was performed using case series data from the Provant Wound Registry, which consists of demographic characteristics and wound healing outcomes for patients treated with the Provant Therapy System.
SETTING: : The analysis subset consisted of data from 39 distinct centers, including both residential and ambulatory care facilities.
PARTICIPANTS: : The analysis included data from 89 patients. The majority of patients (89%) were cared for in residential facilities, whereas 11% of patients were cared for in ambulatory care facilities.
MAIN OUTCOME MEASURES: : Specific outcomes that assessed wound healing between the initial time point and at the 4-week follow-up were as follows: percent wound surface area reduction (PWAR), proportion of wounds achieving 50% reduction or greater in wound surface area (50% PWAR), and the rate of wound healing (wound healing trajectory in centimeters squared per day).
MAIN RESULTS: : Overall, there was a 51% median reduction in wound surface area (PWAR) after 4 weeks of PRFE therapy for wounds in the study, with 51% of wounds (56/110) achieving 50% reduction or greater in wound surface area (50% PWAR). Rate of healing measurements for the overall study group showed a median wound healing trajectory of 0.13 cm/d at 4 weeks.
CONCLUSION: : Compared with historical controls and other studies using similar surrogate wound healing markers, these results suggest PRFE therapy is a beneficial adjuvant treatment option for healing chronic pressure ulcers.
Authors:
Teresa Conner-Kerr; Richard A Isenberg
Related Documents :
1527149 - Management of thrombophlebitis in the prepartum period. a case report.
2205019 - Thrombin-antithrombin iii-complex & fibrin degradation products in plasma: surgery and ...
20215909 - The use and limitations of unfractionated heparin.
22336859 - Hydrocolloid dressings for healing diabetic foot ulcers.
19802659 - Prospective randomized controlled trial on the effect of fondaparinux sodium for preven...
7368149 - Low dose heparin in the prevention of deep-vein thrombosis after aortic bifurcation gra...
19738139 - Antiarrhythmics after ablation of atrial fibrillation (5a study).
12796549 - Longitudinal mri study: the effects of azathioprine in ms patients refractory to interf...
15711109 - Pre-surgical finasteride therapy in patients treated endoscopically for benign prostati...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Advances in skin & wound care     Volume:  25     ISSN:  1538-8654     ISO Abbreviation:  Adv Skin Wound Care     Publication Date:  2012 Jun 
Date Detail:
Created Date:  2012-05-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100911021     Medline TA:  Adv Skin Wound Care     Country:  United States    
Other Details:
Languages:  eng     Pagination:  253-60     Citation Subset:  N    
Affiliation:
Teresa Conner-Kerr, PhD, PT, CWS, CLT, is Professor and Chairperson, Department of Physical Therapy, Winston-Salem State University, North Carolina. Richard A. Isenberg, MD, FAPWCA, is Vice President, Regulatory and Clinical Affairs, Regenesis Biomedical Inc, Scottsdale, Arizona.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Use of a blocking primer allows selective amplification of bacterial DNA from microalgae cultures.
Next Document:  Reliability and Predictive Validity of Inlow's 60-Second Diabetic Foot Screen Tool.